Back to Search
SUNEER CHANDER, M.D.
M.D.
Emergency Medicine Physician
NPI: 1932157021Individual
Specialties, Licenses & Credentials
Emergency Medicine PhysicianPrimary
Emergency Medicine
Code: 207P00000X
217010(MA)
Research & Publications (20)
Comparison of nutritional traits variability in selected eighty-seven inbreds from Chinese maize (Zea mays L.) germplasm.
PMID 18620402·J Agric Food Chem·2008
4-observational
Using molecular markers to identify two major loci controlling carotenoid contents in maize grain.
PMID 17960357·Theor Appl Genet·2008
4-observational
In vivo inhibition of angiogenesis by sulphamoylated derivatives of 2-methoxyoestradiol.
PMID 17426705·Br J Cancer·2007
7-preclinical
The role of steroid sulphatase in regulating the oestrogenicity of oestrogen sulphamates.
PMID 15313194·Biochem Biophys Res Commun·2004
4-observational
The in vivo properties of STX243: a potent angiogenesis inhibitor in breast cancer.
PMID 18841154·Br J Cancer·2008
7-preclinical
A new therapeutic strategy against hormone-dependent breast cancer: the preclinical development of a dual aromatase and sulfatase inhibitor.
PMID 18927286·Clin Cancer Res·2008
7-preclinical
Synthesis of aromatase inhibitors and dual aromatase steroid sulfatase inhibitors by linking an arylsulfamate motif to 4-(4H-1,2,4-triazol-4-ylamino)benzonitrile: SAR, crystal structures, in vitro and in vivo activities.
PMID 18816537·ChemMedChem·2008
8-other
Identification of QTL for maize resistance to common smut by using recombinant inbred lines developed from the Chinese hybrid Yuyu22.
PMID 18436989·J Appl Genet·2008
8-other
Cyclin D1 (G870A) polymorphism and risk of cervix cancer: a case control study in north Indian population.
PMID 18548202·Mol Cell Biochem·2008
8-other
17beta-hydroxysteroid dehydrogenase Type 1, and not Type 12, is a target for endocrine therapy of hormone-dependent breast cancer.
PMID 18183589·Int J Cancer·2008
7-preclinical
Anticancer steroid sulfatase inhibitors: synthesis of a potent fluorinated second-generation agent, in vitro and in vivo activities, molecular modeling, and protein crystallography.
PMID 18723489·Mol Cancer Ther·2008
7-preclinical
Efficacy of three potent steroid sulfatase inhibitors: pre-clinical investigations for their use in the treatment of hormone-dependent breast cancer.
PMID 17914670·Breast Cancer Res Treat·2008
7-preclinical
Tissue conditioning materials as functional impression materials.
PMID 17645067·Eur J Prosthodont Restor Dent·2007
6-review
Dual aromatase-sulfatase inhibitors based on the anastrozole template: synthesis, in vitro SAR, molecular modelling and in vivo activity.
PMID 17728860·Org Biomol Chem·2007
8-other
Dual aromatase-sulfatase inhibitors based on the anastrozole template: synthesis, in vitro SAR, molecular modelling and in vivo activity.
PMID 17972413·Org Biomol Chem·2007
7-preclinical
Functional and pharmacokinetic outcomes after a single intravenous infusion of recombinant human erythropoietin in patients with malignant extradural spinal cord compression.
PMID 17305256·Clin Oncol (R Coll Radiol)·2007
3-trial
Residue evaluation of controlled-release formulations of imidacloprid against rice leaf folder.
PMID 17492242·Bull Environ Contam Toxicol·2007
7-preclinical
A case report of langerhans histiocytosis presenting sequentially over a 21-year period with Letterer-Siwe disease, hand-Schuller-Christian disease and eosinophillic granuloma of bone.
PMID 17114962·J Pediatr Hematol Oncol·2006
5-case
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 115 LINCOLN STREET, METROWEST MEDICAL CENTER
FRAMINGHAM, MA 01702 - Phone
- (508) 383-1104
Quick Facts
- NPI
- 1932157021
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile